Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: A randomised, phase 3 trial

The Lancet

Volumn 378, Issue 9809, 2011, Pages 2104-2111

  Warde, Padraig ^a   Mason, Malcolm ^c   Ding, Keyue ^d   Kirkbride, Peter ^f   Brundage, Michael ^e   Cowan, Richard ^j   Gospodarowicz, Mary ^a   Sanders, Karen ^k   Kostashuk, Edmund ^g   Swanson, Greg ^h   Barber, Jim ^b   Hiltz, Andrea ^d   Parmar, Mahesh Kb ^k   Sathya, Jinka ⁱ   Anderson, John ^f   Hayter, Charles ^m   Hetherington, John ^l   Sydes, Matthew R ^k   Parulekar, Wendy ^d  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b VELINDRE CANCER CENTRE   (United Kingdom)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^d NCIC CTG   (Canada)

^e Kingston Regional Cancer Center   (Canada)

^f WESTON PARK HOSPITAL   (United Kingdom)

^g Fraser Valley Cancer Center   (Canada)

^h UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

ⁱ Dr H Bliss Murphy Cancer Clinic ^*  (Canada)

^j CHRISTIE HOSPITAL   (United Kingdom)

^k MRC CLINICAL TRIALS UNIT   (United Kingdom)

^l CASTLE HILL HOSPITAL   (United Kingdom)

^m Carlo Fidani Cancer Center   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; DIARRHEA; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECTUM HEMORRHAGE; SEMINAL VESICLE; URINARY TRACT DISEASE;

EID: 83955165856     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61095-7     Document Type: Article

References (27)

1. J Ferlay, HR Shin, F Bray, D Forman, C Mathers, DM Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2008 2893 2917
2. A Jemal, R Siegel, J Xu, E Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
3. MR Cooperberg, JW Moul, PR Carroll The changing face of prostate cancer J Clin Oncol 23 2005 8146 8151
4. JA Eastham, CP Evans, A Zietman What is the optimal management of high risk, clinically localized prostate cancer? Urol Oncol 28 2010 557 567
5. GJ Fellows, PB Clark, LL Beynon et al. Treatment of advanced localised prostatic cancer by orchiectomy, radiotherapy, or combined treatment. A Medical Research Council Study. Urological Cancer Working Party - Subgroup on Prostatic Cancer Br J Urol 70 1992 304 309
6. SJ Pocock, R Simon Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial Biometrics 31 1975 103 115
7. NK Aaronson, S Ahmedzai, B Bergman et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
8. P Esper, F Mo, G Chodak, M Sinner, D Cella, KJ Pienta Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument Urology 50 1997 920 928
9. AF Monti, A Ostinelli, M Frigerio et al. An ICRU 50 radiotherapy treatment chart Radiother Oncol 35 1995 145 150
10. M Bolla, G van Tienhoven, P Warde et al. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study Lancet Oncol 11 2010 1066 1073
11. M Bolla, D Gonzalez, P Warde et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin N Engl J Med 337 1997 295 300
12. R Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
13. G Lan, D DeMets Discrete sequential boundaries for clinical trials Biometrika 70 1983 659 663
14. A Widmark, O Klepp, A Solberg et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial Lancet 373 2009 301 308
15. D Cella, MB Nichol, D Eton, JB Nelson, P Mulani Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy - prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer Value Health 12 2009 124 129
16. D Osoba, A Bezjak, M Brundage, B Zee, D Tu, J Pater Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group Eur J Cancer 41 2005 280 287
17. M Bolla, TM de Reijke, G van Tienhoven et al. Duration of androgen suppression in the treatment of prostate cancer N Engl J Med 360 2009 2516 2527
18. EM Horwitz, K Bae, GE Hanks et al. Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer J Clin Oncol 26 2008 2497 2504
19. SM Alibhai, M Duong-Hua, AM Cheung et al. Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 men J Urol 184 2010 918 923
20. SM Alibhai, HZ Mohamedali Cardiac and cognitive effects of androgen deprivation therapy: are they real? Curr Oncol 17 suppl 2 2010 S55 S64
21. NL Keating, AJ O'Malley, MR Smith Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer J Clin Oncol 24 2006 4448 4456
22. VB Shahinian, YF Kuo, JL Freeman, JS Goodwin Risk of fracture after androgen deprivation for prostate cancer N Engl J Med 352 2005 154 164
23. KP McMullen, WR Lee A structured literature review to determine the use of the American Society for Therapeutic Radiology and Oncology consensus definition of biochemical failure Urology 61 2003 391 396
24. DA Kuban, SL Tucker, L Dong et al. Long-term results of the M D Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74
25. AL Zietman, ML DeSilvio, JD Slater et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial JAMA 294 2005 1233 1239
26. SA Rosenthal, HM Sandler Treatment strategies for high-risk locally advanced prostate cancer Nat Rev Urol 7 2010 31 38
27. MR Cooperberg, JM Broering, PR Carroll Time trends and local variation in primary treatment of localized prostate cancer J Clin Oncol 28 2010 1117 1123